These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 24831088

  • 1. Defining the critical material attributes of lactose monohydrate in carrier based dry powder inhaler formulations using artificial neural networks.
    Kinnunen H, Hebbink G, Peters H, Shur J, Price R.
    AAPS PharmSciTech; 2014 Aug; 15(4):1009-20. PubMed ID: 24831088
    [Abstract] [Full Text] [Related]

  • 2. An investigation into the effect of fine lactose particles on the fluidization behaviour and aerosolization performance of carrier-based dry powder inhaler formulations.
    Kinnunen H, Hebbink G, Peters H, Shur J, Price R.
    AAPS PharmSciTech; 2014 Aug; 15(4):898-909. PubMed ID: 24756910
    [Abstract] [Full Text] [Related]

  • 3. Extrinsic lactose fines improve dry powder inhaler formulation performance of a cohesive batch of budesonide via agglomerate formation and consequential co-deposition.
    Kinnunen H, Hebbink G, Peters H, Huck D, Makein L, Price R.
    Int J Pharm; 2015 Jan 15; 478(1):53-59. PubMed ID: 25448567
    [Abstract] [Full Text] [Related]

  • 4. Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers.
    Hassoun M, Ho S, Muddle J, Buttini F, Parry M, Hammond M, Forbes B.
    Int J Pharm; 2015 Jul 25; 490(1-2):360-7. PubMed ID: 25987210
    [Abstract] [Full Text] [Related]

  • 5. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW, Schneider M, Morrical BD, Imanidis G.
    J Pharm Sci; 2018 Apr 25; 107(4):984-998. PubMed ID: 29247741
    [Abstract] [Full Text] [Related]

  • 6. Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.
    Sun Y, Qin L, Li J, Su J, Song R, Zhang X, Guan J, Mao S.
    AAPS J; 2021 Apr 15; 23(3):55. PubMed ID: 33856568
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H, Palakodaty S, Clark A, York P, Tzannis ST.
    Int J Pharm; 2004 Aug 20; 281(1-2):55-66. PubMed ID: 15288343
    [Abstract] [Full Text] [Related]

  • 13. Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.
    Kim KS, Kim JH, Jin SG, Kim DW, Kim JO, Yong CS, Youn YS, Oh KT, Woo JS, Choi HG.
    Pharm Dev Technol; 2018 Feb 20; 23(2):158-166. PubMed ID: 28612675
    [Abstract] [Full Text] [Related]

  • 14. Spherical agglomerates of lactose as potential carriers for inhalation.
    Zellnitz S, Lamešić D, Stranzinger S, Pinto JT, Planinšek O, Paudel A.
    Eur J Pharm Biopharm; 2021 Feb 20; 159():11-20. PubMed ID: 33358941
    [Abstract] [Full Text] [Related]

  • 15. Elucidation of lactose fine size and drug shape on rheological properties and aerodynamic behavior of dry powders for inhalation.
    Sun Y, Yu D, Li J, Zhao J, Feng Y, Zhang X, Mao S.
    Eur J Pharm Biopharm; 2022 Oct 20; 179():47-57. PubMed ID: 36029939
    [Abstract] [Full Text] [Related]

  • 16. Powder flow analysis: A simple method to indicate the ideal amount of lactose fines in dry powder inhaler formulations.
    Hertel M, Schwarz E, Kobler M, Hauptstein S, Steckel H, Scherließ R.
    Int J Pharm; 2018 Jan 15; 535(1-2):59-67. PubMed ID: 29100914
    [Abstract] [Full Text] [Related]

  • 17. Performance indicators for carrier-based DPIs: Carrier surface properties for capsule filling and API properties for in vitro aerosolisation.
    Faulhammer E, Zellnitz S, Wutscher T, Stranzinger S, Zimmer A, Paudel A.
    Int J Pharm; 2018 Jan 30; 536(1):326-335. PubMed ID: 29217472
    [Abstract] [Full Text] [Related]

  • 18. Synergistic effect of magnesium stearate and fine lactose in improving aerosolization performance of fluticasone propionate in dry powder formulation.
    He X, Li J, Wen X, Ma S, An Y, Zhang X, Guan J, Mao S.
    Int J Pharm; 2024 Oct 25; 664():124609. PubMed ID: 39163928
    [Abstract] [Full Text] [Related]

  • 19. Role of dispersion enhancer selection in the development of novel tratinterol hydrochloride dry powder inhalation formulations.
    Liu T, Tong S, Liao Q, Pan L, Cheng M, Rantanen J, Cun D, Yang M.
    Int J Pharm; 2023 Mar 25; 635():122702. PubMed ID: 36773729
    [Abstract] [Full Text] [Related]

  • 20. Formulation and evaluation of insulin dry powder for inhalation.
    Mahesh Kumar T, Misra A.
    Drug Dev Ind Pharm; 2006 Jul 25; 32(6):677-86. PubMed ID: 16885123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.